Human SNP ID | rs7224000 |
---|---|
Human chromosome | chr17 |
Human SNP position | 67414818 |
Pig chromosome | chr12 |
Pig SNP position | 14135150 |
PubMed ID | 24503447 |
---|---|
Journal | Antivir Ther |
Link | www.ncbi.nlm.nih.gov/pubmed/24503447 |
Study | Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor. |
Disease/Trait | Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels) |
Initial sample | 176 European ancestry individuals |
Replication sample | NA |
Region | 17q24.2 |
Chromosome id | chr17 |
Chromosome position | 67414818 |
Reported gene | PITPNC1 |
Mapped gene | PITPNC1 |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 26207 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs7224000-? |
SNPs | rs7224000 |
Merged | 0 |
SNP id current | 7224000 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | NR |
P value | 0.000003 |
Pvalue mlog | 5.52287874528033 |
P value text | |
Or beta | 0.12 |
%95 Ci | [NR] unit increase |
Platform | Illumina [4466593] |
CNV | N |
Mapped trait | response to protease inhibitor, hepatitis C infection, bilirubin measurement |
Mapped trait URI | http://www.ebi.ac.uk/efo/EFO_0005657, http://www.ebi.ac.uk/efo/EFO_0003047, http://www.ebi.ac.uk/efo/EFO_0004570 |
Study accession | GCST002349 |